Interview with Carlos Apellaniz, Healthcare Partner, Korn/Ferry Mexico
You have been working as a general manager in the healthcare industry for many years before coming to Korn/Ferry. In your words, what have been the most drastic changes that…
Address: Montes Urales 505, 3rd Floor Lomas de Chapultepec Del. Miguel Hidalgo 11000 Mexico DF ,Mexico
Tel: 55 5095 9500
Web: http://https//www.kornferry.com/
Since our inception, clients have trusted Korn/Ferry to help them recruit world-class leadership talent. Building on this heritage, today we are a single source for a wide range of leadership and talent consulting services. From our nearly 80 offices in 40 countries, we assist organizations in attracting, engaging, developing, and retaining their people. Services range from executive recruitment to leadership development programs, enterprise learning, succession planning and recruitment outsourcing.
As one of the world’s top ranked leadership and talent consulting firms, we build more effective people, teams, and organizations to drive accelerated business results, and achieve sustainable change. We work with Boards, CEOs, CHROs, and CLOs to align their talent strategy with their business strategy — bringing together deep consulting expertise with the most advanced research-validated methodologies available. Our goal is to transform the lives of the people and organizations we serve, and the worldwide leadership and talent industry.
You have been working as a general manager in the healthcare industry for many years before coming to Korn/Ferry. In your words, what have been the most drastic changes that…
COVID-19 has highlighted the importance of secure regional pharma supply chains across the globe, not least in Mexico where the state of Hidalgo has signed a deal with six Indian…
Pfizer, one of the world’s largest pharmaceutical companies, has been active in Mexico since 1951, and has been led in Mexico by Argentinean Constanza Losada as country president and CEO…
Recently appointed CEO and president for Pfizer Mexico, Constanza Losada, outlines the exciting challenge of taking on leadership for such an important affiliate during the COVID-19 pandemic and how Pfizer…
Biogen Mexico’s Luis Calderon discusses establishing the affiliate, the opportunities apparent in the Mexican neurodegenerative disease market, and the impact of the country’s ongoing health reforms. In my experience,…
A compilation of the top 10 pharmaceutical companies in the Mexican pharmaceutical market based on IQVIA data from February MAT 2020. Four of the top ten companies are Mexican: PISA,…
UCB’s Omar Lugo Aguirre outlines the company’s response to the COVID-19 pandemic in Mexico, countering stigmas around neurodegenerative and mental diseases, and the abundant opportunities that Mexico and the region…
Americo Garcia oversees Latin American operations for Canadian generics player Apotex. He outlines the firm’s impressive growth in the region in recent years – expanding both in terms of portfolio…
Inosan Biopharma General Manager Juan Lopez de Silanes outlines the Mexican family company’s recent milestones, including an impressive internationalisation push in the Middle East & Africa Region, how demand for…
Sara Montero, managing director of Lundbeck Mexico, Central America and Andean countries since January 2020, explains her key priorities and the importance of the region for Lundbeck, highlights the current…
Mauricio Guizar, newly appointed general manager of Ipsen Mexico since October 2019, shares his first impression of the French specialty care player’s operations in Mexico, the significance of being the…
Francisco Kuri Breña, director of new developments at local Mexican player Landsteiner, shares the company’s existing positioning as one of the top 10 suppliers of generic medicines to the Mexican…
CP Maria del Socorro España Lomeli, executive director of the Mexican generics industry association ANAFAM, discusses the challenges with regard to the ‘new rules of the game’ in Mexico’s healthcare…
See our Cookie Privacy Policy Here
